Our findings suggest a novel mechanism for ICC carcinogenesis in which LKB1 underexpression enhances multiple signaling pathways including Wnt/β-catenin to promote disease progression. This evidence concerns the gene STK11 and intrahepatic cholangiocarcinoma.